{"id":"https://openalex.org/W4391879141","doi":"https://doi.org/10.1158/2767-9764.25233509.v1","title":"FIGURE 1 from Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3\u03b2 Activation and c-Myc and Mcl-1 Proteasomal Degradation","display_name":"FIGURE 1 from Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3\u03b2 Activation and c-Myc and Mcl-1 Proteasomal Degradation","publication_year":2024,"publication_date":"2024-02-16","ids":{"openalex":"https://openalex.org/W4391879141","doi":"https://doi.org/10.1158/2767-9764.25233509.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.25233509.v1","doi":"https://doi.org/10.1158/2767-9764.25233509.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.25233509.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.25233509.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026057477","display_name":"Jonelle K. Lee","orcid":"https://orcid.org/0000-0001-7250-6818","observed_orcids":["https://orcid.org/0000-0001-7250-6818"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonelle K. Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7250-6818","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040265273","display_name":"Aditi Chatterjee","orcid":"https://orcid.org/0000-0003-0595-3866","observed_orcids":["https://orcid.org/0000-0003-0595-3866"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aditi Chatterjee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0595-3866","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082280429","display_name":"Mario Scarpa","orcid":"https://orcid.org/0000-0001-6885-6778","observed_orcids":["https://orcid.org/0000-0001-6885-6778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Scarpa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6885-6778","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029789482","display_name":"Christopher M. Bailey","orcid":"https://orcid.org/0000-0002-2259-0502","observed_orcids":["https://orcid.org/0000-0002-2259-0502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher M. Bailey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2259-0502","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054706220","display_name":"Sandrine Niyongere","orcid":"https://orcid.org/0000-0001-9254-0095","observed_orcids":["https://orcid.org/0000-0001-9254-0095"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandrine Niyongere","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9254-0095","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084575052","display_name":"Prerna Singh","orcid":"https://orcid.org/0000-0002-7808-6049","observed_orcids":["https://orcid.org/0000-0002-7808-6049"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prerna Singh","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7808-6049","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020357166","display_name":"Moaath K. Mustafa Ali","orcid":"https://orcid.org/0000-0003-3289-2333","observed_orcids":["https://orcid.org/0000-0003-3289-2333"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moaath K. Mustafa Ali","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3289-2333","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064415728","display_name":"Shivani Kapoor","orcid":"https://orcid.org/0009-0003-6060-6637","observed_orcids":["https://orcid.org/0009-0003-6060-6637"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shivani Kapoor","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-6060-6637","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027415109","display_name":"Yin Wang","orcid":"https://orcid.org/0000-0002-4749-3768","observed_orcids":["https://orcid.org/0000-0002-4749-3768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yin Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4749-3768","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056803476","display_name":"Giovannino Silvestri","orcid":"https://orcid.org/0000-0001-5911-6997","observed_orcids":["https://orcid.org/0000-0001-5911-6997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovannino Silvestri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5911-6997","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049910941","display_name":"Maria R. Baer","orcid":"https://orcid.org/0000-0002-9499-1348","observed_orcids":["https://orcid.org/0000-0002-9499-1348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria R. Baer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9499-1348","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12582","display_name":"Flavonoids in Medical Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pim-kinase-inhibitors","display_name":"PIM kinase inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.9739999771118164},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.9850000143051147},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/azd1208","display_name":"AZD1208","score":0.953000009059906},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5799999833106995},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7390000224113464},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7480000257492065},{"id":"https://openalex.org/keywords/gsk-3beta","display_name":"GSK3\u03b2","score":0.8460000157356262},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9079999923706055},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.996999979019165},{"id":"https://openalex.org/keywords/proteasomal-degradation","display_name":"proteasomal degradation","score":0.8790000081062317},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.815654993057251},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6024430990219116},{"id":"https://openalex.org/C2779679103","wikidata":"https://www.wikidata.org/wiki/Q5251805","display_name":"Degradation (telecommunications)","level":2,"score":0.5927828550338745},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5905661582946777},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5827746391296387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21148744225502014},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1646423637866974},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0758112370967865},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.07439017295837402},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2767-9764.25233509.v1","doi":"https://doi.org/10.1158/2767-9764.25233509.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.25233509.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.25233509.v1","doi":"https://doi.org/10.1158/2767-9764.25233509.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.25233509.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391884481","https://openalex.org/W4391313605","https://openalex.org/W4391879140","https://openalex.org/W4391883955","https://openalex.org/W4391879157","https://openalex.org/W2887253947","https://openalex.org/W2919286019","https://openalex.org/W4362401588","https://openalex.org/W4391884514","https://openalex.org/W4253668898"],"abstract_inverted_index":{"Pim":[0,40],"inhibitor":[1,25,41],"and":[2,17,31,36,66,93,95,120,136],"gilteritinib":[3,26,110],"combination":[4,138,149],"treatment":[5],"is":[6],"synergistic":[7],"in":[8,57,101,121,127],"cells":[9,19,88,97],"with":[10,22,109],"FLT3-ITD.":[11],"A,C,":[12],"Apoptosis":[13,60],"induction.":[14],"Ba/F3-ITD,":[15],"MV4-11,":[16],"MOLM-14":[18,96],"were":[20,104,140],"treated":[21,105],"the":[23,39,124,133],"FLT3":[24],"(15":[27],"nmol/L":[28,33],"for":[29,34,54,106],"Ba/F3-ITD":[30,87],"10":[32],"MV4-11":[35,94],"MOLM-14)":[37],"and/or":[38,111],"AZD1208":[42,112],"(1":[43,48],"\u00b5mol/L;":[44,49],"A)":[45],"or":[46,51,114],"TP-3654":[47,115],"C)":[50],"DMSO":[52],"control":[53],"48":[55,107],"hours":[56,108],"triplicate":[58],"experiments.":[59],"was":[61,130,146],"analyzed":[62],"by":[63,70,132,142,148],"Annexin":[64],"V":[65],"PI":[67],"staining,":[68],"measured":[69,131],"flow":[71],"cytometry.":[72],"****,":[73],"P":[74,78,82],"<":[75,79,83,152],"0.0001;":[76],"***,":[77],"0.001;":[80],"**,":[81],"0.01.":[84],"B,D,":[85],"Cytotoxicity.":[86],"seeded":[89],"at":[90,98,123],"5,000":[91],"cells/well":[92,100],"10,000":[99],"96-well":[102],"plates":[103],"(B)":[113],"(D)":[116],"as":[117],"single":[118],"drugs":[119],"combinations":[122],"concentrations":[125],"shown,":[126],"triplicate.":[128],"Cytotoxicity":[129],"WST-1":[134],"assay,":[135],"drug":[137],"effects":[139],"determined":[141],"Chou-Talalay":[143],"analysis.":[144],"Synergism":[145],"defined":[147],"index":[150],"values":[151],"0.8.":[153]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-02-17T00:00:00"}